13th IMPACCT Real-World Evidence Summit

The 13th IMPACCT Real-World Evidence Summit offers you the unique opportunity to consolidate, innovate and optimize your RWE strategy at all stages of the drug development lifecycle.

Connect with 140+ industry pioneers from Pfizer, AstraZeneca, Alexion, Moderna, and Boehringer Ingelheim, as they share first-hand case studies in fortifying data quality, validating use of AI and predictive modeling in data analysis, leveraging RWE to support regulatory submissions and more.

BIA members can contact BioPartner UK for a 10% discount code